In vitro expanded alloantigen-specific CD4+CD25+ regulatory T cell treatment for the induction of donor-specific transplantation tolerance

    Research output: Contribution to journalArticlepeer-review

    21 Citations (Scopus)

    Abstract

    The key goal in clinical transplantation is the induction of donor-specific transplantation tolerance to minimise the morbidity and mortality associated with long-term immunosuppression. Naturally occurring CD4(+)CD25(+) regulatory T cells (Tregs) expressing forkhead transcript factor FoxP3 play a crucial role in the prevention of autoimmunity, and appear to mediate transplantation tolerance, and these cells can have indirect allospecificity for donor antigens. Here we show that self-reactive human CD4(+)CD25(+) Tregs can be subverted into allopeptide-specific cells in vitro and be expanded to large cell numbers, and that similar in vitro expanded murine CD4(+)CD25(+) Tregs with indirect allospecificity were capable of inducing donor-specific experimental transplantation tolerance. These data provide a platform for clinical studies using CD4(+)CD25(+) Tregs with indirect allospecificity as potential reagents for the induction of donor-specific transplantation tolerance.
    Original languageEnglish
    Pages (from-to)1879 - 1882
    Number of pages4
    JournalINTERNATIONAL IMMUNOPHARMACOLOGY
    Volume6
    Issue number13-14
    Early online date15 Aug 2006
    DOIs
    Publication statusPublished - 20 Dec 2006

    Fingerprint

    Dive into the research topics of 'In vitro expanded alloantigen-specific CD4+CD25+ regulatory T cell treatment for the induction of donor-specific transplantation tolerance'. Together they form a unique fingerprint.

    Cite this